Cost-effectiveness of HIV screening in high-income countries: A systematic review

In 2012, over 35 million people lived with human immunodeficiency virus (HIV) infection worldwide, and of these, approximately 2.2 million lived in high-income countries [1]. Moreover, a large percentage of the infected population are unaware of their status; for example, in the US, 21% of people living with HIV ignore this condition [2]. Knowledge of the HIV-serostatus and early treatment can improve both the survival and the quality of life of infected subjects [3]. In addition to the individual benefits, the early identification of HIV may have a role in reducing the transmission from index patients to uninfected persons [4 –6].

Source: Health Policy - March 26, 2018 Category: Health Management Authors: Fabrizio Bert, Maria Rosaria Gualano, Paolo Biancone, Valerio Brescia, Elisa Camussi, Maria Martorana, Silvana Secinaro, Roberta Siliquini Source Type: research